Overall, our study reveals a hitherto unrecognized link between IDH1 mutation and IRF3/7 in antiviral immunity and provides a theoretical basis for clinical treatment of IDH1mut gliomas by oncolytic viruses. Here, IDH1 is linked to glioma.